© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
March 19, 2021
Optimizing care and managing challenges for patients with ADHD during the COVID-19 pandemic and advice for clinicians educating patients and families on disease management.
Rakesh Jain, MD, MPH, shares his thoughts on whether drug holidays are appropriate for children taking medication for ADHD.
A discussion on the recent development of investigational serotonin norepinephrine modulating agent (SNMA), SPN-812, for the treatment of ADHD in adults.
Rakesh Jain, MD, MPH, considers the evidence-based recommended hierarchy in the choice of medications for the treatment of pediatric and adult ADHD.
Predominantly Persistent IRF in nAMD Eyes Linked to Worse Long-Term Visual Acuity
Mean Changes in Visual Acuity Linked to Anti-VEGF Treatment Intensity
Higher Mortality Rate for NAFLD Patients With Fatigue